Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akemi Kakino

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 11, 2016
Modified LDL functions in human and LOX-1-mediated signal transductionsAkemi Kakino, Tatsuya Sawamura
Current Opinion in Lipidology|July 11, 2012
LOX-1: a multiligand receptor at the crossroads of response to danger signalsTatsuya Sawamura, Akemi Kakino, Yoshiko Fujita
Journal of Atherosclerosis and Thrombosis|April 27, 2017
LOX-1 in Ischemic StrokeTatsuya Sawamura, Yoshiko Fujita, Sayaka Horiuchi, et al.
Trends in Cardiovascular Medicine|January 29, 2017
Editorial commentary: L5: An LDL fraction in which pathogenic activity of LDL is concentratedTatsuya Sawamura, Yoshiko Fujita, Sayaka Horiuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 28, 2016
Developmental Endothelial Locus-1 (Del-1) Inhibits Oxidized Low-Density Lipoprotein Activity by Direct Binding, and Its Overexpression Attenuates Atherogenesis in MiceAkemi Kakino, Yoshiko Fujita, Atsushi Nakano, et al.
Cardiovascular Drugs and Therapy|August 2, 2011
The discovery of LOX-1, its ligands and clinical significanceRyo Yoshimoto, Yoshiko Fujita, Akemi Kakino, et al.
Clinical Chemistry|August 9, 2011
Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activationYoshiko Fujita, Saburo Yamaguchi, Akemi Kakino, et al.
Journal of Atherosclerosis and Thrombosis|July 6, 2011
An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB) - utilization of anti-LOX-1 single- chain antibody fused to apoB fragmentShin Iwamoto, Yoshiko Fujita, Akemi Kakino, et al.
Scientific Reports|August 4, 2021
Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse modelMarumi Ohno, Akemi Kakino, Toshiki Sekiya, et al.
Clinical Chemistry|January 16, 2010
C-reactive protein uptake by macrophage cell line via class-A scavenger receptorYoshiko Fujita, Akemi Kakino, Mariko Harada-Shiba, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|February 11, 2016
Modified LDL functions in human and LOX-1-mediated signal transductionsAkemi Kakino, Tatsuya Sawamura
Current Opinion in Lipidology|July 11, 2012
LOX-1: a multiligand receptor at the crossroads of response to danger signalsTatsuya Sawamura, Akemi Kakino, Yoshiko Fujita
Journal of Atherosclerosis and Thrombosis|April 27, 2017
LOX-1 in Ischemic StrokeTatsuya Sawamura, Yoshiko Fujita, Sayaka Horiuchi, et al.
Trends in Cardiovascular Medicine|January 29, 2017
Editorial commentary: L5: An LDL fraction in which pathogenic activity of LDL is concentratedTatsuya Sawamura, Yoshiko Fujita, Sayaka Horiuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 28, 2016
Developmental Endothelial Locus-1 (Del-1) Inhibits Oxidized Low-Density Lipoprotein Activity by Direct Binding, and Its Overexpression Attenuates Atherogenesis in MiceAkemi Kakino, Yoshiko Fujita, Atsushi Nakano, et al.
Cardiovascular Drugs and Therapy|August 2, 2011
The discovery of LOX-1, its ligands and clinical significanceRyo Yoshimoto, Yoshiko Fujita, Akemi Kakino, et al.
Clinical Chemistry|August 9, 2011
Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activationYoshiko Fujita, Saburo Yamaguchi, Akemi Kakino, et al.
Journal of Atherosclerosis and Thrombosis|July 6, 2011
An alternative protein standard to measure activity of LOX-1 ligand containing apoB (LAB) - utilization of anti-LOX-1 single- chain antibody fused to apoB fragmentShin Iwamoto, Yoshiko Fujita, Akemi Kakino, et al.
Scientific Reports|August 4, 2021
Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse modelMarumi Ohno, Akemi Kakino, Toshiki Sekiya, et al.
Clinical Chemistry|January 16, 2010
C-reactive protein uptake by macrophage cell line via class-A scavenger receptorYoshiko Fujita, Akemi Kakino, Mariko Harada-Shiba, et al.
Pageof 5